Episode 2 (December 22, 2023): Interview with President and CEO of Tome Biosciences, Rahul Kakkar; intelligent lab partner using LLMs; AI for antimicrobials; mRNA vaccine production in Africa; Moderna’s positive cancer vaccine data.
Listed below are key references to the GEN stories, media and other items discussed in this episode of Touching Base:
The Next Chapter in Genome Editing? Tome Emerges from Stealth with $213M
By Alex Philippidis, GEN, December 19, 2023.
Artificial Intelligence-Based Lab Partner Designs, Runs Experiments in the Lab
GEN, December 20, 2023.
BioNTech Advances Plans for mRNA Vaccine Production in Africa by 2025
GEN, December 19, 2023.
Explainable AI Directs Small Molecule Structural Class Drug Discovery
By Jonathan Grinstein, GEN, December 20, 2023.
StockWatch: Positive Cancer Vaccine Data Wows Moderna Investors
By Alex Philippidis, GEN Edge, December 18, 2023.
To access all episodes of Touching Base click here.
